nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—ACHE—Irinotecan—hematologic cancer	0.211	0.346	CbGbCtD
Pralidoxime—BCHE—Triamcinolone—hematologic cancer	0.168	0.275	CbGbCtD
Pralidoxime—BCHE—Irinotecan—hematologic cancer	0.127	0.209	CbGbCtD
Pralidoxime—BCHE—Cisplatin—hematologic cancer	0.104	0.17	CbGbCtD
Pralidoxime—Haemoglobin—Alitretinoin—hematologic cancer	0.000702	0.00238	CcSEcCtD
Pralidoxime—Haemorrhage—Alitretinoin—hematologic cancer	0.000699	0.00237	CcSEcCtD
Pralidoxime—Somnolence—Dasatinib—hematologic cancer	0.000698	0.00236	CcSEcCtD
Pralidoxime—Somnolence—Bexarotene—hematologic cancer	0.000698	0.00236	CcSEcCtD
Pralidoxime—Haemoglobin—Ifosfamide—hematologic cancer	0.000694	0.00235	CcSEcCtD
Pralidoxime—Tachycardia—Cladribine—hematologic cancer	0.000692	0.00234	CcSEcCtD
Pralidoxime—Haemorrhage—Ifosfamide—hematologic cancer	0.000691	0.00234	CcSEcCtD
Pralidoxime—Muscular weakness—Prednisolone—hematologic cancer	0.000686	0.00232	CcSEcCtD
Pralidoxime—Pain—Procarbazine—hematologic cancer	0.000685	0.00232	CcSEcCtD
Pralidoxime—Dizziness—Nelarabine—hematologic cancer	0.000674	0.00228	CcSEcCtD
Pralidoxime—Pain—Dasatinib—hematologic cancer	0.000671	0.00227	CcSEcCtD
Pralidoxime—Pain—Bexarotene—hematologic cancer	0.000671	0.00227	CcSEcCtD
Pralidoxime—Inflammation—Methotrexate—hematologic cancer	0.000671	0.00227	CcSEcCtD
Pralidoxime—Pain—Fludarabine—hematologic cancer	0.00067	0.00227	CcSEcCtD
Pralidoxime—Vision blurred—Bortezomib—hematologic cancer	0.000668	0.00226	CcSEcCtD
Pralidoxime—Haemoglobin—Mitoxantrone—hematologic cancer	0.000659	0.00223	CcSEcCtD
Pralidoxime—Haemoglobin—Irinotecan—hematologic cancer	0.000659	0.00223	CcSEcCtD
Pralidoxime—Dizziness—Methoxsalen—hematologic cancer	0.000658	0.00223	CcSEcCtD
Pralidoxime—Haemorrhage—Mitoxantrone—hematologic cancer	0.000656	0.00222	CcSEcCtD
Pralidoxime—Haemorrhage—Irinotecan—hematologic cancer	0.000656	0.00222	CcSEcCtD
Pralidoxime—Agitation—Bortezomib—hematologic cancer	0.000651	0.00221	CcSEcCtD
Pralidoxime—Haemoglobin—Gemcitabine—hematologic cancer	0.000642	0.00217	CcSEcCtD
Pralidoxime—Somnolence—Imatinib—hematologic cancer	0.000641	0.00217	CcSEcCtD
Pralidoxime—Haemorrhage—Gemcitabine—hematologic cancer	0.000639	0.00216	CcSEcCtD
Pralidoxime—Headache—Nelarabine—hematologic cancer	0.000639	0.00216	CcSEcCtD
Pralidoxime—Pain—Chlorambucil—hematologic cancer	0.000634	0.00215	CcSEcCtD
Pralidoxime—Tachycardia—Melphalan—hematologic cancer	0.000631	0.00214	CcSEcCtD
Pralidoxime—Dizziness—Clofarabine—hematologic cancer	0.000631	0.00214	CcSEcCtD
Pralidoxime—Dizziness—Daunorubicin—hematologic cancer	0.000631	0.00214	CcSEcCtD
Pralidoxime—Muscular weakness—Triamcinolone—hematologic cancer	0.000631	0.00214	CcSEcCtD
Pralidoxime—Somnolence—Cladribine—hematologic cancer	0.00063	0.00213	CcSEcCtD
Pralidoxime—Dizziness—Pentostatin—hematologic cancer	0.000628	0.00213	CcSEcCtD
Pralidoxime—Dizziness—Anagrelide—hematologic cancer	0.000628	0.00213	CcSEcCtD
Pralidoxime—Inflammation—Epirubicin—hematologic cancer	0.000628	0.00213	CcSEcCtD
Pralidoxime—Headache—Methoxsalen—hematologic cancer	0.000624	0.00211	CcSEcCtD
Pralidoxime—Vision blurred—Thiotepa—hematologic cancer	0.000623	0.00211	CcSEcCtD
Pralidoxime—Pain—Nilotinib—hematologic cancer	0.00062	0.0021	CcSEcCtD
Pralidoxime—Pain—Imatinib—hematologic cancer	0.000617	0.00209	CcSEcCtD
Pralidoxime—Tachycardia—Lenalidomide—hematologic cancer	0.000614	0.00208	CcSEcCtD
Pralidoxime—Agitation—Thiotepa—hematologic cancer	0.000607	0.00206	CcSEcCtD
Pralidoxime—Pain—Cladribine—hematologic cancer	0.000606	0.00205	CcSEcCtD
Pralidoxime—Nausea—Nelarabine—hematologic cancer	0.000605	0.00205	CcSEcCtD
Pralidoxime—Vision blurred—Thalidomide—hematologic cancer	0.000602	0.00204	CcSEcCtD
Pralidoxime—Headache—Clofarabine—hematologic cancer	0.000598	0.00202	CcSEcCtD
Pralidoxime—Headache—Daunorubicin—hematologic cancer	0.000598	0.00202	CcSEcCtD
Pralidoxime—Headache—Anagrelide—hematologic cancer	0.000595	0.00202	CcSEcCtD
Pralidoxime—Headache—Pentostatin—hematologic cancer	0.000595	0.00202	CcSEcCtD
Pralidoxime—Nausea—Methoxsalen—hematologic cancer	0.000591	0.002	CcSEcCtD
Pralidoxime—Agitation—Thalidomide—hematologic cancer	0.000587	0.00199	CcSEcCtD
Pralidoxime—Pain—Vinblastine—hematologic cancer	0.000581	0.00197	CcSEcCtD
Pralidoxime—Inflammation—Doxorubicin—hematologic cancer	0.000581	0.00197	CcSEcCtD
Pralidoxime—Vision blurred—Carmustine—hematologic cancer	0.000579	0.00196	CcSEcCtD
Pralidoxime—Nausea—Mercaptopurine—hematologic cancer	0.000574	0.00195	CcSEcCtD
Pralidoxime—Headache—Idarubicin—hematologic cancer	0.000574	0.00194	CcSEcCtD
Pralidoxime—Vision blurred—Alitretinoin—hematologic cancer	0.000573	0.00194	CcSEcCtD
Pralidoxime—Muscular weakness—Betamethasone—hematologic cancer	0.000572	0.00194	CcSEcCtD
Pralidoxime—Muscular weakness—Dexamethasone—hematologic cancer	0.000572	0.00194	CcSEcCtD
Pralidoxime—Nausea—Daunorubicin—hematologic cancer	0.000567	0.00192	CcSEcCtD
Pralidoxime—Nausea—Clofarabine—hematologic cancer	0.000567	0.00192	CcSEcCtD
Pralidoxime—Vision blurred—Ifosfamide—hematologic cancer	0.000567	0.00192	CcSEcCtD
Pralidoxime—Tachycardia—Bortezomib—hematologic cancer	0.000565	0.00191	CcSEcCtD
Pralidoxime—Agitation—Carmustine—hematologic cancer	0.000564	0.00191	CcSEcCtD
Pralidoxime—Nausea—Pentostatin—hematologic cancer	0.000564	0.00191	CcSEcCtD
Pralidoxime—Nausea—Anagrelide—hematologic cancer	0.000564	0.00191	CcSEcCtD
Pralidoxime—Agitation—Alitretinoin—hematologic cancer	0.000559	0.00189	CcSEcCtD
Pralidoxime—Somnolence—Lenalidomide—hematologic cancer	0.000559	0.00189	CcSEcCtD
Pralidoxime—Headache—Teniposide—hematologic cancer	0.000558	0.00189	CcSEcCtD
Pralidoxime—Pain—Melphalan—hematologic cancer	0.000553	0.00187	CcSEcCtD
Pralidoxime—Agitation—Ifosfamide—hematologic cancer	0.000552	0.00187	CcSEcCtD
Pralidoxime—Tachycardia—Vinorelbine—hematologic cancer	0.000551	0.00187	CcSEcCtD
Pralidoxime—Somnolence—Hydroxyurea—hematologic cancer	0.000551	0.00187	CcSEcCtD
Pralidoxime—Dizziness—Busulfan—hematologic cancer	0.000546	0.00185	CcSEcCtD
Pralidoxime—Nausea—Idarubicin—hematologic cancer	0.000544	0.00184	CcSEcCtD
Pralidoxime—Haemoglobin—Prednisolone—hematologic cancer	0.000541	0.00183	CcSEcCtD
Pralidoxime—Agitation—Vincristine—hematologic cancer	0.000539	0.00182	CcSEcCtD
Pralidoxime—Haemorrhage—Prednisolone—hematologic cancer	0.000538	0.00182	CcSEcCtD
Pralidoxime—Vision blurred—Mitoxantrone—hematologic cancer	0.000538	0.00182	CcSEcCtD
Pralidoxime—Pain—Lenalidomide—hematologic cancer	0.000538	0.00182	CcSEcCtD
Pralidoxime—Pain—Hydroxyurea—hematologic cancer	0.00053	0.0018	CcSEcCtD
Pralidoxime—Dizziness—Procarbazine—hematologic cancer	0.00053	0.00179	CcSEcCtD
Pralidoxime—Nausea—Teniposide—hematologic cancer	0.000529	0.00179	CcSEcCtD
Pralidoxime—Tachycardia—Thiotepa—hematologic cancer	0.000526	0.00178	CcSEcCtD
Pralidoxime—Dizziness—Bexarotene—hematologic cancer	0.000519	0.00176	CcSEcCtD
Pralidoxime—Dizziness—Dasatinib—hematologic cancer	0.000519	0.00176	CcSEcCtD
Pralidoxime—Headache—Busulfan—hematologic cancer	0.000517	0.00175	CcSEcCtD
Pralidoxime—Tachycardia—Thalidomide—hematologic cancer	0.000509	0.00172	CcSEcCtD
Pralidoxime—Headache—Procarbazine—hematologic cancer	0.000502	0.0017	CcSEcCtD
Pralidoxime—Muscular weakness—Prednisone—hematologic cancer	0.000498	0.00169	CcSEcCtD
Pralidoxime—Haemoglobin—Triamcinolone—hematologic cancer	0.000497	0.00168	CcSEcCtD
Pralidoxime—Haemorrhage—Triamcinolone—hematologic cancer	0.000495	0.00168	CcSEcCtD
Pralidoxime—Pain—Bortezomib—hematologic cancer	0.000495	0.00168	CcSEcCtD
Pralidoxime—Headache—Dasatinib—hematologic cancer	0.000492	0.00167	CcSEcCtD
Pralidoxime—Headache—Bexarotene—hematologic cancer	0.000492	0.00167	CcSEcCtD
Pralidoxime—Pain—Bleomycin—hematologic cancer	0.000491	0.00166	CcSEcCtD
Pralidoxime—Headache—Fludarabine—hematologic cancer	0.000491	0.00166	CcSEcCtD
Pralidoxime—Nausea—Busulfan—hematologic cancer	0.00049	0.00166	CcSEcCtD
Pralidoxime—Tachycardia—Carmustine—hematologic cancer	0.000489	0.00166	CcSEcCtD
Pralidoxime—Vision blurred—Cisplatin—hematologic cancer	0.000488	0.00165	CcSEcCtD
Pralidoxime—Tachycardia—Alitretinoin—hematologic cancer	0.000484	0.00164	CcSEcCtD
Pralidoxime—Pain—Vinorelbine—hematologic cancer	0.000483	0.00164	CcSEcCtD
Pralidoxime—Dizziness—Nilotinib—hematologic cancer	0.00048	0.00162	CcSEcCtD
Pralidoxime—Somnolence—Thiotepa—hematologic cancer	0.00048	0.00162	CcSEcCtD
Pralidoxime—Dizziness—Imatinib—hematologic cancer	0.000477	0.00162	CcSEcCtD
Pralidoxime—Nausea—Procarbazine—hematologic cancer	0.000476	0.00161	CcSEcCtD
Pralidoxime—Dizziness—Cladribine—hematologic cancer	0.000469	0.00159	CcSEcCtD
Pralidoxime—Nausea—Dasatinib—hematologic cancer	0.000466	0.00158	CcSEcCtD
Pralidoxime—Nausea—Bexarotene—hematologic cancer	0.000466	0.00158	CcSEcCtD
Pralidoxime—Nausea—Fludarabine—hematologic cancer	0.000465	0.00158	CcSEcCtD
Pralidoxime—Somnolence—Thalidomide—hematologic cancer	0.000464	0.00157	CcSEcCtD
Pralidoxime—Pain—Thiotepa—hematologic cancer	0.000461	0.00156	CcSEcCtD
Pralidoxime—Tachycardia—Mitoxantrone—hematologic cancer	0.000455	0.00154	CcSEcCtD
Pralidoxime—Headache—Nilotinib—hematologic cancer	0.000454	0.00154	CcSEcCtD
Pralidoxime—Headache—Imatinib—hematologic cancer	0.000452	0.00153	CcSEcCtD
Pralidoxime—Haemoglobin—Dexamethasone—hematologic cancer	0.000451	0.00153	CcSEcCtD
Pralidoxime—Haemoglobin—Betamethasone—hematologic cancer	0.000451	0.00153	CcSEcCtD
Pralidoxime—Dizziness—Vinblastine—hematologic cancer	0.000449	0.00152	CcSEcCtD
Pralidoxime—Haemorrhage—Dexamethasone—hematologic cancer	0.000449	0.00152	CcSEcCtD
Pralidoxime—Haemorrhage—Betamethasone—hematologic cancer	0.000449	0.00152	CcSEcCtD
Pralidoxime—Pain—Thalidomide—hematologic cancer	0.000446	0.00151	CcSEcCtD
Pralidoxime—Somnolence—Carmustine—hematologic cancer	0.000445	0.00151	CcSEcCtD
Pralidoxime—Headache—Cladribine—hematologic cancer	0.000444	0.0015	CcSEcCtD
Pralidoxime—Diplopia—Epirubicin—hematologic cancer	0.000442	0.0015	CcSEcCtD
Pralidoxime—Vision blurred—Prednisolone—hematologic cancer	0.000441	0.00149	CcSEcCtD
Pralidoxime—Somnolence—Alitretinoin—hematologic cancer	0.000441	0.00149	CcSEcCtD
Pralidoxime—Nausea—Chlorambucil—hematologic cancer	0.000441	0.00149	CcSEcCtD
Pralidoxime—Somnolence—Ifosfamide—hematologic cancer	0.000436	0.00148	CcSEcCtD
Pralidoxime—Nausea—Nilotinib—hematologic cancer	0.000431	0.00146	CcSEcCtD
Pralidoxime—Pain—Carmustine—hematologic cancer	0.000429	0.00145	CcSEcCtD
Pralidoxime—Nausea—Imatinib—hematologic cancer	0.000428	0.00145	CcSEcCtD
Pralidoxime—Headache—Vinblastine—hematologic cancer	0.000426	0.00144	CcSEcCtD
Pralidoxime—Pain—Alitretinoin—hematologic cancer	0.000425	0.00144	CcSEcCtD
Pralidoxime—Nausea—Cladribine—hematologic cancer	0.000421	0.00143	CcSEcCtD
Pralidoxime—Pain—Ifosfamide—hematologic cancer	0.00042	0.00142	CcSEcCtD
Pralidoxime—Dizziness—Lenalidomide—hematologic cancer	0.000416	0.00141	CcSEcCtD
Pralidoxime—Somnolence—Mitoxantrone—hematologic cancer	0.000414	0.0014	CcSEcCtD
Pralidoxime—Somnolence—Irinotecan—hematologic cancer	0.000414	0.0014	CcSEcCtD
Pralidoxime—Tachycardia—Cisplatin—hematologic cancer	0.000413	0.0014	CcSEcCtD
Pralidoxime—Dizziness—Hydroxyurea—hematologic cancer	0.00041	0.00139	CcSEcCtD
Pralidoxime—Pain—Vincristine—hematologic cancer	0.000409	0.00139	CcSEcCtD
Pralidoxime—Diplopia—Doxorubicin—hematologic cancer	0.000409	0.00139	CcSEcCtD
Pralidoxime—Nausea—Vinblastine—hematologic cancer	0.000404	0.00137	CcSEcCtD
Pralidoxime—Somnolence—Gemcitabine—hematologic cancer	0.000403	0.00137	CcSEcCtD
Pralidoxime—Pain—Irinotecan—hematologic cancer	0.000398	0.00135	CcSEcCtD
Pralidoxime—Pain—Mitoxantrone—hematologic cancer	0.000398	0.00135	CcSEcCtD
Pralidoxime—Headache—Lenalidomide—hematologic cancer	0.000394	0.00133	CcSEcCtD
Pralidoxime—Haemoglobin—Prednisone—hematologic cancer	0.000393	0.00133	CcSEcCtD
Pralidoxime—Haemorrhage—Prednisone—hematologic cancer	0.000391	0.00132	CcSEcCtD
Pralidoxime—Muscular weakness—Epirubicin—hematologic cancer	0.00039	0.00132	CcSEcCtD
Pralidoxime—Headache—Hydroxyurea—hematologic cancer	0.000388	0.00132	CcSEcCtD
Pralidoxime—Pain—Gemcitabine—hematologic cancer	0.000388	0.00131	CcSEcCtD
Pralidoxime—Nausea—Melphalan—hematologic cancer	0.000384	0.0013	CcSEcCtD
Pralidoxime—Dizziness—Bortezomib—hematologic cancer	0.000383	0.0013	CcSEcCtD
Pralidoxime—Tachycardia—Etoposide—hematologic cancer	0.000378	0.00128	CcSEcCtD
Pralidoxime—Dizziness—Vinorelbine—hematologic cancer	0.000374	0.00127	CcSEcCtD
Pralidoxime—Nausea—Lenalidomide—hematologic cancer	0.000373	0.00126	CcSEcCtD
Pralidoxime—Tachycardia—Prednisolone—hematologic cancer	0.000373	0.00126	CcSEcCtD
Pralidoxime—Nausea—Hydroxyurea—hematologic cancer	0.000368	0.00125	CcSEcCtD
Pralidoxime—Drowsiness—Methotrexate—hematologic cancer	0.000364	0.00123	CcSEcCtD
Pralidoxime—Headache—Bortezomib—hematologic cancer	0.000362	0.00123	CcSEcCtD
Pralidoxime—Pain—Cisplatin—hematologic cancer	0.000362	0.00123	CcSEcCtD
Pralidoxime—Muscular weakness—Doxorubicin—hematologic cancer	0.000361	0.00122	CcSEcCtD
Pralidoxime—Dizziness—Thiotepa—hematologic cancer	0.000357	0.00121	CcSEcCtD
Pralidoxime—Headache—Vinorelbine—hematologic cancer	0.000354	0.0012	CcSEcCtD
Pralidoxime—Dizziness—Thalidomide—hematologic cancer	0.000345	0.00117	CcSEcCtD
Pralidoxime—Somnolence—Etoposide—hematologic cancer	0.000344	0.00117	CcSEcCtD
Pralidoxime—Nausea—Bortezomib—hematologic cancer	0.000344	0.00116	CcSEcCtD
Pralidoxime—Tachycardia—Triamcinolone—hematologic cancer	0.000343	0.00116	CcSEcCtD
Pralidoxime—Nausea—Bleomycin—hematologic cancer	0.000341	0.00116	CcSEcCtD
Pralidoxime—Drowsiness—Epirubicin—hematologic cancer	0.000341	0.00115	CcSEcCtD
Pralidoxime—Headache—Thiotepa—hematologic cancer	0.000338	0.00114	CcSEcCtD
Pralidoxime—Nausea—Vinorelbine—hematologic cancer	0.000336	0.00114	CcSEcCtD
Pralidoxime—Dizziness—Carmustine—hematologic cancer	0.000331	0.00112	CcSEcCtD
Pralidoxime—Pain—Etoposide—hematologic cancer	0.000331	0.00112	CcSEcCtD
Pralidoxime—Haemoglobin—Methotrexate—hematologic cancer	0.000328	0.00111	CcSEcCtD
Pralidoxime—Dizziness—Alitretinoin—hematologic cancer	0.000328	0.00111	CcSEcCtD
Pralidoxime—Headache—Thalidomide—hematologic cancer	0.000327	0.00111	CcSEcCtD
Pralidoxime—Pain—Prednisolone—hematologic cancer	0.000327	0.00111	CcSEcCtD
Pralidoxime—Haemorrhage—Methotrexate—hematologic cancer	0.000327	0.00111	CcSEcCtD
Pralidoxime—Dizziness—Ifosfamide—hematologic cancer	0.000324	0.0011	CcSEcCtD
Pralidoxime—Vision blurred—Prednisone—hematologic cancer	0.000321	0.00109	CcSEcCtD
Pralidoxime—Nausea—Thiotepa—hematologic cancer	0.00032	0.00109	CcSEcCtD
Pralidoxime—Dizziness—Vincristine—hematologic cancer	0.000316	0.00107	CcSEcCtD
Pralidoxime—Drowsiness—Doxorubicin—hematologic cancer	0.000315	0.00107	CcSEcCtD
Pralidoxime—Headache—Carmustine—hematologic cancer	0.000314	0.00106	CcSEcCtD
Pralidoxime—Agitation—Prednisone—hematologic cancer	0.000313	0.00106	CcSEcCtD
Pralidoxime—Tachycardia—Betamethasone—hematologic cancer	0.000311	0.00105	CcSEcCtD
Pralidoxime—Tachycardia—Dexamethasone—hematologic cancer	0.000311	0.00105	CcSEcCtD
Pralidoxime—Headache—Alitretinoin—hematologic cancer	0.000311	0.00105	CcSEcCtD
Pralidoxime—Nausea—Thalidomide—hematologic cancer	0.00031	0.00105	CcSEcCtD
Pralidoxime—Dizziness—Irinotecan—hematologic cancer	0.000308	0.00104	CcSEcCtD
Pralidoxime—Haemoglobin—Epirubicin—hematologic cancer	0.000307	0.00104	CcSEcCtD
Pralidoxime—Haemorrhage—Epirubicin—hematologic cancer	0.000306	0.00104	CcSEcCtD
Pralidoxime—Pain—Triamcinolone—hematologic cancer	0.000301	0.00102	CcSEcCtD
Pralidoxime—Headache—Vincristine—hematologic cancer	0.0003	0.00102	CcSEcCtD
Pralidoxime—Nausea—Carmustine—hematologic cancer	0.000298	0.00101	CcSEcCtD
Pralidoxime—Nausea—Alitretinoin—hematologic cancer	0.000295	0.000999	CcSEcCtD
Pralidoxime—Headache—Mitoxantrone—hematologic cancer	0.000292	0.000989	CcSEcCtD
Pralidoxime—Headache—Irinotecan—hematologic cancer	0.000292	0.000989	CcSEcCtD
Pralidoxime—Nausea—Ifosfamide—hematologic cancer	0.000291	0.000987	CcSEcCtD
Pralidoxime—Haemoglobin—Doxorubicin—hematologic cancer	0.000284	0.000963	CcSEcCtD
Pralidoxime—Headache—Gemcitabine—hematologic cancer	0.000284	0.000963	CcSEcCtD
Pralidoxime—Nausea—Vincristine—hematologic cancer	0.000284	0.000962	CcSEcCtD
Pralidoxime—Haemorrhage—Doxorubicin—hematologic cancer	0.000283	0.000958	CcSEcCtD
Pralidoxime—Nausea—Irinotecan—hematologic cancer	0.000277	0.000937	CcSEcCtD
Pralidoxime—Nausea—Mitoxantrone—hematologic cancer	0.000277	0.000937	CcSEcCtD
Pralidoxime—Pain—Dexamethasone—hematologic cancer	0.000273	0.000924	CcSEcCtD
Pralidoxime—Pain—Betamethasone—hematologic cancer	0.000273	0.000924	CcSEcCtD
Pralidoxime—Tachycardia—Prednisone—hematologic cancer	0.000271	0.000918	CcSEcCtD
Pralidoxime—Nausea—Gemcitabine—hematologic cancer	0.00027	0.000913	CcSEcCtD
Pralidoxime—Vision blurred—Methotrexate—hematologic cancer	0.000268	0.000908	CcSEcCtD
Pralidoxime—Dizziness—Etoposide—hematologic cancer	0.000256	0.000868	CcSEcCtD
Pralidoxime—Dizziness—Prednisolone—hematologic cancer	0.000253	0.000856	CcSEcCtD
Pralidoxime—Nausea—Cisplatin—hematologic cancer	0.000251	0.000851	CcSEcCtD
Pralidoxime—Vision blurred—Epirubicin—hematologic cancer	0.000251	0.00085	CcSEcCtD
Pralidoxime—Agitation—Epirubicin—hematologic cancer	0.000245	0.000828	CcSEcCtD
Pralidoxime—Headache—Etoposide—hematologic cancer	0.000243	0.000822	CcSEcCtD
Pralidoxime—Headache—Prednisolone—hematologic cancer	0.000239	0.000811	CcSEcCtD
Pralidoxime—Dizziness—Triamcinolone—hematologic cancer	0.000232	0.000787	CcSEcCtD
Pralidoxime—Vision blurred—Doxorubicin—hematologic cancer	0.000232	0.000786	CcSEcCtD
Pralidoxime—Nausea—Etoposide—hematologic cancer	0.00023	0.00078	CcSEcCtD
Pralidoxime—Nausea—Prednisolone—hematologic cancer	0.000227	0.000769	CcSEcCtD
Pralidoxime—Agitation—Doxorubicin—hematologic cancer	0.000226	0.000767	CcSEcCtD
Pralidoxime—Headache—Triamcinolone—hematologic cancer	0.00022	0.000746	CcSEcCtD
Pralidoxime—Tachycardia—Epirubicin—hematologic cancer	0.000212	0.000718	CcSEcCtD
Pralidoxime—Dizziness—Dexamethasone—hematologic cancer	0.000211	0.000714	CcSEcCtD
Pralidoxime—Dizziness—Betamethasone—hematologic cancer	0.000211	0.000714	CcSEcCtD
Pralidoxime—Nausea—Triamcinolone—hematologic cancer	0.000209	0.000707	CcSEcCtD
Pralidoxime—Somnolence—Methotrexate—hematologic cancer	0.000206	0.000699	CcSEcCtD
Pralidoxime—Headache—Dexamethasone—hematologic cancer	0.0002	0.000677	CcSEcCtD
Pralidoxime—Headache—Betamethasone—hematologic cancer	0.0002	0.000677	CcSEcCtD
Pralidoxime—Pain—Methotrexate—hematologic cancer	0.000198	0.000672	CcSEcCtD
Pralidoxime—Tachycardia—Doxorubicin—hematologic cancer	0.000196	0.000664	CcSEcCtD
Pralidoxime—Somnolence—Epirubicin—hematologic cancer	0.000193	0.000654	CcSEcCtD
Pralidoxime—Nausea—Dexamethasone—hematologic cancer	0.000189	0.000642	CcSEcCtD
Pralidoxime—Nausea—Betamethasone—hematologic cancer	0.000189	0.000642	CcSEcCtD
Pralidoxime—Pain—Epirubicin—hematologic cancer	0.000186	0.000629	CcSEcCtD
Pralidoxime—Dizziness—Prednisone—hematologic cancer	0.000184	0.000622	CcSEcCtD
Pralidoxime—Somnolence—Doxorubicin—hematologic cancer	0.000179	0.000605	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	0.000176	0.00187	CbGpPWpGaD
Pralidoxime—Headache—Prednisone—hematologic cancer	0.000174	0.000589	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	0.000174	0.00184	CbGpPWpGaD
Pralidoxime—Pain—Doxorubicin—hematologic cancer	0.000172	0.000582	CcSEcCtD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CG—hematologic cancer	0.000172	0.00182	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	0.000171	0.00181	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.00017	0.0018	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.000167	0.00176	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	0.000166	0.00175	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MUC1—hematologic cancer	0.000165	0.00175	CbGpPWpGaD
Pralidoxime—Nausea—Prednisone—hematologic cancer	0.000165	0.000559	CcSEcCtD
Pralidoxime—ACHE—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000164	0.00174	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PHYH—hematologic cancer	0.000162	0.00171	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—FTCD—hematologic cancer	0.000162	0.00171	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GMPS—hematologic cancer	0.000162	0.00171	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPLP1—hematologic cancer	0.000162	0.00171	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.00016	0.00169	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	0.00016	0.00169	CbGpPWpGaD
Pralidoxime—Dizziness—Methotrexate—hematologic cancer	0.000153	0.00052	CcSEcCtD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CG—hematologic cancer	0.000153	0.00162	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.000153	0.00161	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CD—hematologic cancer	0.000151	0.0016	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.000151	0.00159	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	0.000149	0.00157	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.000149	0.00157	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—TUBB2A—hematologic cancer	0.000148	0.00157	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SMPD3—hematologic cancer	0.000148	0.00156	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.000148	0.00156	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000146	0.00155	CbGpPWpGaD
Pralidoxime—Headache—Methotrexate—hematologic cancer	0.000145	0.000493	CcSEcCtD
Pralidoxime—BCHE—Metabolism—PHYH—hematologic cancer	0.000144	0.00153	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GMPS—hematologic cancer	0.000144	0.00153	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—FTCD—hematologic cancer	0.000144	0.00153	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPLP1—hematologic cancer	0.000144	0.00153	CbGpPWpGaD
Pralidoxime—Dizziness—Epirubicin—hematologic cancer	0.000144	0.000487	CcSEcCtD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.000143	0.00151	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	0.000143	0.00151	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3R1—hematologic cancer	0.000143	0.00151	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	0.000141	0.00149	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	0.000141	0.00149	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—IL6—hematologic cancer	0.00014	0.00148	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	0.00014	0.00148	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	0.000138	0.00146	CbGpPWpGaD
Pralidoxime—Nausea—Methotrexate—hematologic cancer	0.000138	0.000467	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	0.000137	0.00145	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	0.000137	0.00145	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.000136	0.00144	CbGpPWpGaD
Pralidoxime—Headache—Epirubicin—hematologic cancer	0.000136	0.000461	CcSEcCtD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CD—hematologic cancer	0.000135	0.00142	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.000135	0.00142	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	0.000134	0.00142	CbGpPWpGaD
Pralidoxime—Dizziness—Doxorubicin—hematologic cancer	0.000133	0.00045	CcSEcCtD
Pralidoxime—BCHE—Metabolism of proteins—TUBB2A—hematologic cancer	0.000132	0.0014	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SMPD3—hematologic cancer	0.000132	0.0014	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MME—hematologic cancer	0.000132	0.00139	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.000132	0.00139	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CB—hematologic cancer	0.000132	0.00139	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—SUMO1—hematologic cancer	0.00013	0.00138	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CMA1—hematologic cancer	0.00013	0.00138	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ASNS—hematologic cancer	0.000129	0.00137	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—B3GAT1—hematologic cancer	0.000129	0.00137	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—DCK—hematologic cancer	0.000129	0.00137	CbGpPWpGaD
Pralidoxime—Nausea—Epirubicin—hematologic cancer	0.000129	0.000437	CcSEcCtD
Pralidoxime—ACHE—Metabolism of proteins—SPHK1—hematologic cancer	0.000128	0.00135	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3R1—hematologic cancer	0.000127	0.00135	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	0.000126	0.00134	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	0.000126	0.00133	CbGpPWpGaD
Pralidoxime—Headache—Doxorubicin—hematologic cancer	0.000126	0.000426	CcSEcCtD
Pralidoxime—ACHE—Neuronal System—PRKCG—hematologic cancer	0.000126	0.00133	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	0.000123	0.0013	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	0.000123	0.0013	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	0.000123	0.0013	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HDC—hematologic cancer	0.000123	0.0013	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000122	0.00129	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.00012	0.00127	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	0.00012	0.00127	CbGpPWpGaD
Pralidoxime—Nausea—Doxorubicin—hematologic cancer	0.000119	0.000404	CcSEcCtD
Pralidoxime—BCHE—Metabolism of proteins—MME—hematologic cancer	0.000118	0.00124	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CB—hematologic cancer	0.000117	0.00124	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	0.000117	0.00124	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CMA1—hematologic cancer	0.000116	0.00123	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—SUMO1—hematologic cancer	0.000116	0.00123	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—B3GAT1—hematologic cancer	0.000115	0.00122	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—DCK—hematologic cancer	0.000115	0.00122	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ASNS—hematologic cancer	0.000115	0.00122	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	0.000114	0.00121	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPS14—hematologic cancer	0.000114	0.00121	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—SPHK1—hematologic cancer	0.000114	0.0012	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PTEN—hematologic cancer	0.000114	0.0012	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	0.000113	0.00119	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—PRKCG—hematologic cancer	0.000112	0.00119	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CDA—hematologic cancer	0.000112	0.00119	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	0.000112	0.00118	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HDC—hematologic cancer	0.000109	0.00116	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000108	0.00115	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PC—hematologic cancer	0.000108	0.00114	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000107	0.00113	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	0.000106	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	0.000104	0.0011	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GBA—hematologic cancer	0.000104	0.0011	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC35B2—hematologic cancer	0.000104	0.0011	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	0.000102	0.00108	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPS14—hematologic cancer	0.000102	0.00108	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PTEN—hematologic cancer	0.000102	0.00107	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000101	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CDA—hematologic cancer	0.0001	0.00106	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—EIF4EBP1—hematologic cancer	9.99e-05	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PC—hematologic cancer	9.63e-05	0.00102	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTAP—hematologic cancer	9.54e-05	0.00101	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	9.53e-05	0.00101	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	9.34e-05	0.000987	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CREB1—hematologic cancer	9.31e-05	0.000985	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GBA—hematologic cancer	9.3e-05	0.000983	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC35B2—hematologic cancer	9.3e-05	0.000983	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—HSPA5—hematologic cancer	9.24e-05	0.000977	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—BRAF—hematologic cancer	9.2e-05	0.000972	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	9.09e-05	0.000961	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	9.07e-05	0.000959	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—MDM2—hematologic cancer	8.97e-05	0.000949	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CALR—hematologic cancer	8.96e-05	0.000947	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—EIF4EBP1—hematologic cancer	8.91e-05	0.000942	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	8.79e-05	0.00093	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	8.77e-05	0.000927	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—FBXW7—hematologic cancer	8.66e-05	0.000916	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	8.58e-05	0.000907	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTAP—hematologic cancer	8.51e-05	0.000899	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—FHL2—hematologic cancer	8.5e-05	0.000899	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	8.37e-05	0.000885	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AGRN—hematologic cancer	8.34e-05	0.000881	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CREB1—hematologic cancer	8.31e-05	0.000878	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—HSPA5—hematologic cancer	8.25e-05	0.000872	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—BRAF—hematologic cancer	8.2e-05	0.000867	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	8.14e-05	0.00086	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CA—hematologic cancer	8.03e-05	0.000849	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CALR—hematologic cancer	7.99e-05	0.000845	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	7.92e-05	0.000838	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—IDH2—hematologic cancer	7.9e-05	0.000835	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMMR—hematologic cancer	7.9e-05	0.000835	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—FBXW7—hematologic cancer	7.73e-05	0.000817	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—MDM2—hematologic cancer	7.71e-05	0.000815	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—FHL2—hematologic cancer	7.58e-05	0.000802	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	7.5e-05	0.000792	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.45e-05	0.000788	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AGRN—hematologic cancer	7.44e-05	0.000786	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ARNTL—hematologic cancer	7.43e-05	0.000785	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	7.29e-05	0.000771	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	7.27e-05	0.000769	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CA9—hematologic cancer	7.23e-05	0.000764	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ACP5—hematologic cancer	7.23e-05	0.000764	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CA—hematologic cancer	7.16e-05	0.000757	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOR2—hematologic cancer	7.13e-05	0.000754	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—IDH2—hematologic cancer	7.05e-05	0.000745	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMMR—hematologic cancer	7.05e-05	0.000745	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—MDM2—hematologic cancer	6.87e-05	0.000727	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—IDH1—hematologic cancer	6.79e-05	0.000718	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	6.79e-05	0.000718	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	6.74e-05	0.000712	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCC3—hematologic cancer	6.72e-05	0.00071	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTO1—hematologic cancer	6.72e-05	0.00071	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TXN—hematologic cancer	6.72e-05	0.00071	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.65e-05	0.000703	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ARNTL—hematologic cancer	6.63e-05	0.000701	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SPHK1—hematologic cancer	6.57e-05	0.000695	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CA9—hematologic cancer	6.45e-05	0.000682	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ACP5—hematologic cancer	6.45e-05	0.000682	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOR2—hematologic cancer	6.36e-05	0.000673	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—UGT1A1—hematologic cancer	6.32e-05	0.000668	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.19e-05	0.000654	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CRABP1—hematologic cancer	6.14e-05	0.00065	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC22A1—hematologic cancer	6.14e-05	0.00065	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—IDH1—hematologic cancer	6.06e-05	0.000641	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCC3—hematologic cancer	5.99e-05	0.000634	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TXN—hematologic cancer	5.99e-05	0.000634	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTO1—hematologic cancer	5.99e-05	0.000634	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALOX5—hematologic cancer	5.99e-05	0.000633	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.99e-05	0.000633	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SPHK1—hematologic cancer	5.87e-05	0.00062	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NUP98—hematologic cancer	5.8e-05	0.000613	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—UGT1A1—hematologic cancer	5.64e-05	0.000596	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOA3—hematologic cancer	5.63e-05	0.000595	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ADCY7—hematologic cancer	5.63e-05	0.000595	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NUP214—hematologic cancer	5.59e-05	0.000591	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.53e-05	0.000585	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.52e-05	0.000583	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC22A1—hematologic cancer	5.48e-05	0.00058	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CRABP1—hematologic cancer	5.48e-05	0.00058	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCG2—hematologic cancer	5.48e-05	0.000579	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTR—hematologic cancer	5.48e-05	0.000579	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ENO2—hematologic cancer	5.37e-05	0.000568	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALOX5—hematologic cancer	5.34e-05	0.000565	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTT1—hematologic cancer	5.21e-05	0.000551	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NUP98—hematologic cancer	5.17e-05	0.000547	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.13e-05	0.000542	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SDC1—hematologic cancer	5.09e-05	0.000538	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.06e-05	0.000535	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOA3—hematologic cancer	5.02e-05	0.000531	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ADCY7—hematologic cancer	5.02e-05	0.000531	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NUP214—hematologic cancer	4.99e-05	0.000527	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.94e-05	0.000522	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.92e-05	0.000521	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCG2—hematologic cancer	4.89e-05	0.000517	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTR—hematologic cancer	4.89e-05	0.000517	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.86e-05	0.000514	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.8e-05	0.000508	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ENO2—hematologic cancer	4.79e-05	0.000507	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTT1—hematologic cancer	4.65e-05	0.000491	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.59e-05	0.000486	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.58e-05	0.000484	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SDC1—hematologic cancer	4.54e-05	0.00048	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CCL2—hematologic cancer	4.45e-05	0.000471	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.34e-05	0.000459	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NQO1—hematologic cancer	4.33e-05	0.000458	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CD44—hematologic cancer	4.33e-05	0.000458	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.28e-05	0.000453	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.24e-05	0.000448	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—HRAS—hematologic cancer	4.23e-05	0.000447	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.1e-05	0.000433	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYCS—hematologic cancer	4.1e-05	0.000433	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSP90AA1—hematologic cancer	4.07e-05	0.00043	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CCL2—hematologic cancer	3.97e-05	0.00042	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NQO1—hematologic cancer	3.86e-05	0.000408	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CD44—hematologic cancer	3.86e-05	0.000408	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.78e-05	0.0004	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—HRAS—hematologic cancer	3.77e-05	0.000399	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.66e-05	0.000387	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYCS—hematologic cancer	3.65e-05	0.000386	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSP90AA1—hematologic cancer	3.63e-05	0.000384	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTP1—hematologic cancer	3.61e-05	0.000382	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.49e-05	0.000369	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCB1—hematologic cancer	3.42e-05	0.000361	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTM1—hematologic cancer	3.32e-05	0.000351	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NCOR1—hematologic cancer	3.32e-05	0.000351	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.27e-05	0.000346	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTP1—hematologic cancer	3.22e-05	0.000341	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.12e-05	0.000329	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCB1—hematologic cancer	3.05e-05	0.000322	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTM1—hematologic cancer	2.96e-05	0.000313	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NCOR1—hematologic cancer	2.96e-05	0.000313	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTHFR—hematologic cancer	2.93e-05	0.00031	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTHFR—hematologic cancer	2.62e-05	0.000277	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.58e-05	0.000273	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CG—hematologic cancer	2.46e-05	0.00026	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.31e-05	0.000244	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CREBBP—hematologic cancer	2.28e-05	0.000242	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CG—hematologic cancer	2.2e-05	0.000232	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CD—hematologic cancer	2.17e-05	0.000229	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALB—hematologic cancer	2.14e-05	0.000226	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3R1—hematologic cancer	2.05e-05	0.000216	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CREBBP—hematologic cancer	2.04e-05	0.000215	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CD—hematologic cancer	1.93e-05	0.000204	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALB—hematologic cancer	1.91e-05	0.000202	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CB—hematologic cancer	1.89e-05	0.0002	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3R1—hematologic cancer	1.82e-05	0.000193	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CB—hematologic cancer	1.68e-05	0.000178	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTEN—hematologic cancer	1.63e-05	0.000172	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—EP300—hematologic cancer	1.56e-05	0.000164	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTEN—hematologic cancer	1.46e-05	0.000154	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—EP300—hematologic cancer	1.39e-05	0.000147	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CA—hematologic cancer	1.15e-05	0.000122	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CA—hematologic cancer	1.03e-05	0.000109	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKT1—hematologic cancer	9.4e-06	9.94e-05	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKT1—hematologic cancer	8.39e-06	8.87e-05	CbGpPWpGaD
